 BERLIN, Aug. 12, 2021 GLOBE NEWSWIRE -- atai Life Sciences Nasdaq: ATAI atai, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced the launch of Revixia Life Sciences Revixia, a wholly owned subsidiary developing Salvinorin A SalA to treat a variety of mental health disorders. 